BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 1984191)

  • 1. Aldosterone synthesis in salt-wasting congenital adrenal hyperplasia with complete absence of adrenal 21-hydroxylase.
    Speiser PW; Agdere L; Ueshiba H; White PC; New MI
    N Engl J Med; 1991 Jan; 324(3):145-9. PubMed ID: 1984191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 21-hydroxylase activity in the glomerulosa and fasciculata of the adrenal cortex in congenital adrenal hyperplasia.
    Kuhnle U; Chow D; Rapaport R; Pang S; Levine LS; New MI
    J Clin Endocrinol Metab; 1981 Mar; 52(3):534-44. PubMed ID: 6257750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone production despite absence or defectiveness of the CYP21 genes in two patients with salt-losing congenital adrenal hyperplasia caused by steroid 21-hydroxylase deficiency.
    Koppens PF; Hoogenboezem T; Drop SL; de Muinck-Keizer-Schrama SM; Degenhart HJ
    Clin Endocrinol (Oxf); 1998 Dec; 49(6):815-22. PubMed ID: 10209571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Congenital adrenal hyperplasia].
    Stanić M; Nesović M
    Med Pregl; 1999; 52(11-12):447-54. PubMed ID: 10748766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    White PC; Speiser PW
    Endocr Rev; 2000 Jun; 21(3):245-91. PubMed ID: 10857554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone-to-renin ratio as a marker for disease severity in 21-hydroxylase deficiency congenital adrenal hyperplasia.
    Nimkarn S; Lin-Su K; Berglind N; Wilson RC; New MI
    J Clin Endocrinol Metab; 2007 Jan; 92(1):137-42. PubMed ID: 17032723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin and adrenal steroidogenesis: study of 21-hydroxylase-deficient congenital adrenal hyperplasia.
    Schaison G; Couzinet B; Gourmelen M; Elkik F; Bougneres P
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1390-4. PubMed ID: 7002950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural history of salt-wasting disorders of adrenal and renal origin.
    Rösler A
    J Clin Endocrinol Metab; 1984 Oct; 59(4):689-700. PubMed ID: 6384251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salt wasting in simple virilizing congenital adrenal hyperplasia.
    Frisch H; Battelino T; Schober E; Baumgartner-Parzer S; Nowotny P; Vierhapper H
    J Pediatr Endocrinol Metab; 2001; 14(9):1649-55. PubMed ID: 11795656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splicing mutation in CYP21 associated with delayed presentation of salt-wasting congenital adrenal hyperplasia.
    Kohn B; Day D; Alemzadeh R; Enerio D; Patel SV; Pelczar JV; Speiser PW
    Am J Med Genet; 1995 Jul; 57(3):450-4. PubMed ID: 7677150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salt loss in hypertensive form of congenital adrenal hyperplasia (11-beta-hydroxylase deficiency).
    Zadik Z; Kahana L; Kaufman H; Benderli A; Hochberg Z
    J Clin Endocrinol Metab; 1984 Feb; 58(2):384-7. PubMed ID: 6607265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal salt loss in the hypertensive form of congenital adrenal hyperplasia.
    Holcombe JH; Keenan BS; Nichols BL; Kirkland RT; Clayton GW
    Pediatrics; 1980 Apr; 65(4):777-81. PubMed ID: 6966049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital adrenal hyperplasia: 11beta-hydroxylase deficiency.
    Peter M
    Semin Reprod Med; 2002 Aug; 20(3):249-54. PubMed ID: 12428205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New studies of the 11 beta-hydroxylase and 18-hydroxylase enzymes in the hypertensive form of congenital adrenal hyperplasia.
    Levine LS; Rauh W; Gottesdiener K; Chow D; Gunczler P; Rapaport R; Pang S; Schneider B; New MI
    J Clin Endocrinol Metab; 1980 Feb; 50(2):258-63. PubMed ID: 6243663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined 21- and 11 beta-hydroxylase deficiency in familial congenital adrenal hyperplasia.
    Hurwitz A; Brautbar C; Milwidsky A; Vecsei P; Milewicz A; Navot D; Rösler A
    J Clin Endocrinol Metab; 1985 Apr; 60(4):631-8. PubMed ID: 2982904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary potassium supplementation and sodium restriction stimulate aldosterone synthase but not 11 beta-hydroxylase P-450 messenger ribonucleic acid accumulation in rat adrenals and require angiotensin II production.
    Tremblay A; Parker KL; Lehoux JG
    Endocrinology; 1992 Jun; 130(6):3152-8. PubMed ID: 1597135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital adrenal hyperplasia due to 21 hydroxylase deficiency: from birth to adulthood.
    White PC; Bachega TA
    Semin Reprod Med; 2012 Oct; 30(5):400-9. PubMed ID: 23044877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is salt-wasting in congenital adrenal hyperplasia due to the same gene as the fasciculata defect?
    Stoner E; Dimartino-Nardi J; Kuhnle U; Levine LS; Oberfield SE; New MI
    Clin Endocrinol (Oxf); 1986 Jan; 24(1):9-20. PubMed ID: 3486728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extraadrenal steroid 21-hydroxylase activity in a woman with congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency.
    Winkel CA; Casey ML; Worley RJ; Madden JD; MacDonald PC
    J Clin Endocrinol Metab; 1983 Jan; 56(1):104-7. PubMed ID: 6600168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zona glomerulosa function after life-long suppression in two siblings with the hypertensive virilizing form of congenital adrenal hyperplasia.
    Rodríguez Portales JA; Arteaga E; López Moreno JM; Biglieri EG
    J Clin Endocrinol Metab; 1988 Feb; 66(2):349-54. PubMed ID: 3276723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.